- 2018 - 2019 インテグリンα9β1低分子阻害剤の臨床医薬への展開
- 2017 - 2019 マウス肝線維化を抑制する新規インテグリン抗体の作用機序と治療応用への集大成研究
- 2017 - 2018 インテグリンα8β1阻害抗体の臨床医薬への展開
- 2015 - 2018 Role of polymeric OPN on fibrosis
- 2014 - 2016 A novel anti-integrin monoclonal antibody that attenuates mouse liver fibrosis: Mechanism of action and therapeutic application
- 2014 - 2015 Establishment of ELISA that detect polymeric OPN and its usefulness
- 2013 - 2014 難治性線維化治療薬としてのインテグリン阻害低分子化合物
- 2012 - 2014 Investigation on mechanism for expansion of GM-CSF autoantibody by next generation sequencing.
- 2012 - 2013 Activated hepatic stellate cell specific antibody that attenuates liver fibrosis: mechanism of action and therapeutic use
- 2011 - 2012 好中球生炎症を制御する抗体のステロイド無効の病態に対する効果の検討
- 2009 - 2011 A STUDY ON ROLES OF POLYMERIC OSTEOPONTIN IN PROGRESSION OF PULMONARY FIBROSIS
- 2006 - 2009 Development of New Functional Antibody Technologies
- 2006 - 2007 Investigation of mechanism of pulmonary fibrosis focusing on post-translational modification of osteopontin and its receptor change
- 2004 - 2006 Molecular basis for the control of intractable diseases through manipulation of osteopontin function.
Show all